Top Markets
#1 Verus Coin Verus Coin +45.28%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.62%
#3 Status Status +18.22%
#4 GoPlus Security GoPlus Security +15.77%
#5 Wrapped NXM Wrapped NXM +15.47%
#6 Bedrock Bedrock +12.40%
#7 Ontology Gas Ontology Gas +11.94%
#8 DMT-NAT DMT-NAT +8.80%
#9 Pons Pons +7.62%
#10 Janction Janction +7.37%
Coin of the day
Verus Coin Verus Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Rang in Aktien #33958
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Aktienkurs
$1.83
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$6.53M
Veränderung (1 Tag)
-1.61%
Veränderung (1 Jahr)
-85.57%
Land
US
Handel Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Kategorie

Healthcare
Kursverlauf für Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Höchster Schlusskurs: $1.89 am 2026-08-01

Niedrigster Schlusskurs: $46.78 am 2023-01-01
Kursverlauf der Aktie von Cadrenal Therapeutics, Inc. Common Stock von 2023 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE